Ligua

Ligua EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ligua (7090.T) as of Oct 25, 2026 is -123.47 M JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -159.24 M JPY — a change of -22.46% (higher).

EBITDA

-123.47 MJPY

YoY

-22.46%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ligua is 2026 -123.47 M JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ligua was 2025 -159.24 M JPY. It decreases by -22.46% higher compared to the previous year.

The Ligua EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
65.45 M JPY
Jan 1, 2020
224.33 M JPY
Jan 1, 2021
247.13 M JPY
Jan 1, 2022
158.50 M JPY
Jan 1, 2023
-869.69 M JPY
Jan 1, 2024
118.33 M JPY
Jan 1, 2025
-159.24 M JPY
Jan 1, 2026
-123.47 M JPY
The Ligua EBITDA history
YEAREBITDAYoY
-123.47 MJPY-22.46%
-159.24 MJPY-234.57%
118.33 MJPY-113.61%
-869.69 MJPY-648.70%
158.50 MJPY-35.86%
247.13 MJPY+10.16%
224.33 MJPY+242.74%
65.45 MJPY-59.49%
161.56 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ligua Stock analysis

What does Ligua do? Ligua Inc generates revenue through its Osteopathic Solution segment, which offers Ligoo POS & CRM, a patient information management system for osteopathic clinics, and Reseone, a claim calculation system designed to address financial difficulties and inadequate management education. The Financial Services segment provides insurance agents and financial products intermediaries, targeting institutions seeking to improve their financial strategies and operations. The company serves osteopathic and bone clinics, focusing on solutions for decreased sales and operational inefficiencies. Ligua Inc's primary customers are osteopathic institutions, including treatment centers for judo reduction surgery, which utilize Ligoo POS & CRM for patient management and Reseone for claim processing. The Financial Services segment caters to these same institutions by offering insurance and financial product intermediaries to support their business strategies. The company's products are tailored to address specific challenges in the osteopathic sector, such as financial difficulties and lack of business strategies. The Osteopathic Solution segment's products, Ligoo POS & CRM and Reseone, are sold to osteopathic and bone clinics, while the Financial Services segment provides insurance agents and financial products intermediaries to the same customer base. Both segments target institutions facing operational and financial challenges, with the company's offerings designed to streamline management and improve revenue streams through specialized systems and services. Ligua is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ligua stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ligua is -123.47 M JPY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ligua changed from -159.24 M JPY to -123.47 M JPY, representing a -22.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ligua since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ligua historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ligua

All Key Metrics — Ligua